Blueprint Medicines Corp - Company Profile
Powered by
All the data and insights you need on Blueprint Medicines Corp in one report.
- Save hours of research time and resources with
our up-to-date Blueprint Medicines Corp Strategy Report
- Understand Blueprint Medicines Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Blueprint Medicines Corp Catalyst Calendar
Proactively evaluate Blueprint Medicines Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Blueprint Medicines Corp Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
19 Feb 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
10 Jan 2020 | Phase III Trial Initiation | Blueprint Medicines Corp; Chugai Pharmaceutical Co Ltd; CStone Pharmaceuticals Co Ltd; F. Hoffmann-La Roche Ltd; Labcorp Drug Development | 2616; 4519; BPMC; ROG | pralsetinib | Oncology; Respiratory | Adenocarcinoma; Carcinomas; Germ Cell Tumors; Head And Neck Cancer; Lung Cancer; Lung Disease; Metastatic Lung Cancer; Nerve Sheath Tumor; Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma; Unspecified Respiratory Disorders | Clinical Trial Registry |
31 Dec 2019 | Phase II Trial Results | Blueprint Medicines Corp; Syneos Health Inc | BPMC; SYNH | avapritinib | Gastrointestinal | Systemic Mastocytosis | Insights |
30 Dec 2019 | Phase I/II Trial Initiation | Blueprint Medicines Corp; Catalent Inc; CStone Pharmaceuticals Co Ltd | 2616; BPMC; CTLT | fisogatinib; sugemalimab | Oncology | Hepatocellular Carcinoma; Liver Cancer; Metastatic Hepatocellular Carcinoma (HCC) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer